Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Insmed Incorporated(INSM) | 12,960,538 | 15,397,975 | +2,437,437 | $894.80M | $1.20B | 82.08% | +$306.09M |
| Verona Pharma PlcADS | 810,449 | 3,923,204 | +3,112,755 | $37.64M | $245.98M | 16.81% | +$208.35M |
| Allogene Therapeutics Inc | 0 | 10,449,791 | +10,449,791 | $0 | $16.20M | 1.11% | +$16.20M |
| Geron Corporation(GERN) | 9,569,835 | 0 | -9,569,835 | $33.88M | $0 | — | -$33.88M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 484,515 | 0 | -484,515 | $59.67M | $0 | — | -$59.67M |
| Keros Therapeutics, Inc.(KROS) | 1,687,135 | 0 | -1,687,135 | $26.71M | $0 | — | -$26.71M |
| Nurix Therapeutics, Inc.(NRIX) | 163,681 | 0 | -163,681 | $3.08M | $0 | — | -$3.08M |